Compare CLSK & PBH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | CLSK | PBH |
|---|---|---|
| Founded | 1987 | 1996 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Finance: Consumer Services | Biotechnology: Pharmaceutical Preparations |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 2.4B | 2.5B |
| IPO Year | 2008 | 2004 |
| Metric | CLSK | PBH |
|---|---|---|
| Price | $11.27 | $56.43 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 12 | 3 |
| Target Price | $19.44 | ★ $75.33 |
| AVG Volume (30 Days) | ★ 17.4M | 514.0K |
| Earning Date | 05-07-2026 | 05-07-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 2.88 |
| EPS | N/A | ★ 2.78 |
| Revenue | $766,314,000.00 | ★ $975,777,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | $19.89 | $4.31 |
| P/E Ratio | ★ N/A | $20.36 |
| Revenue Growth | ★ 102.21 | 36.77 |
| 52 Week Low | $7.03 | $51.24 |
| 52 Week High | $23.61 | $88.00 |
| Indicator | CLSK | PBH |
|---|---|---|
| Relative Strength Index (RSI) | 63.98 | 38.80 |
| Support Level | $8.78 | $51.24 |
| Resistance Level | $14.04 | $63.56 |
| Average True Range (ATR) | 0.70 | 2.20 |
| MACD | 0.27 | 0.08 |
| Stochastic Oscillator | 84.11 | 44.99 |
Cleanspark Inc. is a data center developer that, until recently, focused exclusively on bitcoin mining. The company provides scalable, energy-efficient digital infrastructure across the United States. The Company has a sole reporting segment, which is the bitcoin mining segment.
Prestige Consumer Healthcare is one of the largest pure-play over-the-counter healthcare providers. It has a diverse portfolio composed of leading brands in niche consumer health categories. Prestige's key brands include Clear Eyes (redness relief), Dramamine (motion sickness relief), Monistat (vaginal anti-fungal), and Summer's Eve (feminine hygiene), and many of its brands enjoy category leadership and recommendations from medical professionals. The firm mainly plays in North America where it generates roughly 85% of its total revenue, and the remaining sales come from Australia, New Zealand, and certain Asian markets.